Definition
ATC code D07 is a segment of the World Health Organization’s Anatomical Therapeutic Chemical (ATC) Classification System. The code belongs to the “D – Dermatologicals” anatomical group and designates the therapeutic subgroup of antifungal agents intended for topical use.
Structure within the ATC System
- D – Dermatologicals (anatomical main group)
- D07 – Antifungals for topical use (therapeutic subgroup)
This therapeutic subgroup is further divided into pharmacological/chemical subgroups:
| Subgroup | Description | Example agents |
|---|---|---|
| D07AA | Antifungal agents, plain — i.e., single active ingredient | Clotrimazole, Miconazole, Terbinafine |
| D07AB | Antifungal agents, combinations | Clotrimazole + hydrocortisone, Miconazole + betamethasone |
| D07AX | Other antifungal agents, other combinations | Tolnaftate + salicylic acid, Ciclopirox + corticosteroid |
Common Indications
Topical antifungal agents classified under D07 are primarily employed to treat superficial mycotic infections of the skin, nails, and mucous membranes, including:
- Tinea corporis (ringworm)
- Tinea pedis (athlete’s foot)
- Tinea cruris (jock itch)
- Candidiasis of the skin or mucosa (e.g., intertrigo, oral thrush)
- Onychomycosis (fungal nail infection)
Regulatory and Clinical Context
The ATC classification facilitates the systematic collection, analysis, and comparison of drug utilization data across countries and healthcare settings. Codes such as D07 are used in pharmaco‑epidemiology, reimbursement systems, and national prescription monitoring programs.
Representative Products (selected)
| ATC code | Active ingredient(s) | Commercial name (examples) |
|---|---|---|
| D07AA02 | Clotrimazole 1 % | Canesten, Lotrimin |
| D07AA03 | Miconazole nitrate 2 % | Desenex, Daktarin |
| D07AA13 | Terbinafine hydrochloride 1 % | Lamisil |
| D07AB02 | Clotrimazole + hydrocortisone | Lotrimin AF |
| D07AB04 | Miconazole + betamethasone | Daktacort |
| D07AX02 | Tolnaftate + salicylic acid | Tinactin Plus |
Historical Note
The ATC system was first introduced by the WHO in 1971. The D07 subgroup has been maintained through successive revisions, reflecting advances in dermatological pharmacotherapy and the introduction of new topical antifungal agents.
References
- World Health Organization. ATC/DDD Index 2024. WHO Collaborating Centre for Drug Statistics Methodology.
- British National Formulary (BNF) 2024. Sections on topical antifungal preparations.
(All information presented reflects established, peer‑reviewed sources and official WHO classifications.)
